Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Amgen (NQ:AMGN)

327.64 +0.33 (+0.10%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,539,733
Open 328.77
Bid (Size) 325.00 (40)
Ask (Size) 329.91 (80)
Prev. Close 327.31
Today's Range 325.01 - 329.19
52wk Range 257.05 - 346.38
Shares Outstanding 538,500,000
Dividend Yield 2.91%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
The 2026 Pharma Reset: How Industry Giants Are Navigating a New Era of Federal Price Controls
Yesterday marked the official commencement of the first-ever "Maximum Fair Prices" (MFPs) for ten of the most widely used drugs in the Medicare program, a direct result of the Inflation Reduction Act’s... 
Via MarketMinute
Topics Economy Intellectual Property World Trade
News headline image
The Rise of the 'Dividogs': Small-Cap Yield Kings Poised to Lead the 2026 Market Rotation
As the calendar turns to January 2, 2026, the investment landscape is undergoing a tectonic shift. After years of dominance by mega-cap technology giants, the "Great Rotation" has finally reached the... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks

Performance

YTD
N/A
N/A
1 Month
-5.1%
-5.1%
3 Month
+10.0%
+10.0%
6 Month
+11.8%
+11.8%
1 Year
+26.4%
+26.4%

More News

Read More
News headline image
The GLP-1 Pricing Revolution: How Novo Nordisk and Eli Lilly Redefined the Weight-Loss Market for 2026
Via MarketMinute
Topics Economy Intellectual Property
News headline image
1 Safe-and-Steady Stock to Keep an Eye On and 2 We Question
Via StockStory
News headline image
Amgen (AMGN): Buy, Sell, or Hold Post Q3 Earnings?
Via StockStory
Topics Stocks
News headline image
The Trillion-Dollar Apothecary: Inside Eli Lilly’s Era of Metabolic Dominance
Via PredictStreet
Topics Earnings Economy Intellectual Property
News headline image
3 Profitable Stocks with Competitive Advantages
Via StockStory
News headline image
Barking Back: Why the 'Dogs of the Dow' 4-Stock Play is the Contrarian Bet for 2026
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
The Oral Revolution: Novo Nordisk’s High-Stakes Bet on the Wegovy Pill
Via PredictStreet
Topics Economy Intellectual Property World Trade
News headline image
The Trillion-Dollar Pharma: A Deep Dive into Eli Lilly’s (LLY) Dominance in the Weight-Loss Era
Via PredictStreet
Topics Economy Government Intellectual Property
News headline image
The Atomic Architect: How University of Washington’s Generative AI Just Rewrote the Rules of Medicine
Via TokenRing AI
Topics Artificial Intelligence
News headline image
The Weight of Innovation: Eli Lilly’s Dominance in the GLP-1 Era
Via PredictStreet
Topics Economy
Fitch Sees Stable 2026 Outlook For Global Pharma — But Warns Trump Drug Pricing Push Poses Profit Risk ↗
Via Stocktwits
Topics Government
News headline image
SCHD vs. NOBL: Different Paths to Dividend Stability ↗
Via The Motley Fool
Topics ETFs
News headline image
Therapeutics Stocks Q3 In Review: Biogen (NASDAQ:BIIB) Vs Peers
Via StockStory
Topics Artificial Intelligence
News headline image
Trump Strikes New Drug-Price Deals With Roche, Novartis, Merck And Other Pharma Giants ↗
Via Stocktwits
Topics Government World Trade
News headline image
The Great Biotech Re-Shoring: Seres Therapeutics and the New Commodity-Driven Era
Via MarketMinute
Topics Earnings Economy Intellectual Property
News headline image
This Is the 2nd Priciest Stock Market in 155 Years, Which Makes This High-Yield ETF a Genius Buy for 2026 ↗
Via The Motley Fool
Topics Artificial Intelligence ETFs Economy
News headline image
Investors Rotate Out of Big Tech and AI: A Market Reassessment Underway
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
Novartis US Stock Rises On Reports Of White House Pricing Deal Due Friday — Roche Also In Talks ↗
Via Stocktwits
Topics Government World Trade
News headline image
Should You Buy the 5 Highest-Paying Dividend Stocks in the Dow Jones Before 2026? ↗
Via The Motley Fool
Topics Bonds Economy Intellectual Property
News headline image
“Buying the Dip” in 2025: A Strategy Rewarded, But Future Requires Caution and Diversification
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
3 Healthcare Giants Just Raised Dividends—Here’s Who Pays the Most ↗
Via MarketBeat
News headline image
7 Dividend ETFs to Buy With $2,000 and Hold Forever -- Including the Schwab U.S. Dividend Equity ETF (SCHD) ↗
Via The Motley Fool
Topics ETFs
News headline image
1 Dow Jones Stock Worth Your Attention and 2 We Brush Off
Via StockStory
Topics Stocks

Frequently Asked Questions

Is Amgen publicly traded?
Yes, Amgen is publicly traded.
What exchange does Amgen trade on?
Amgen trades on the Nasdaq Stock Market
What is the ticker symbol for Amgen?
The ticker symbol for Amgen is AMGN on the Nasdaq Stock Market
What is the current price of Amgen?
The current price of Amgen is 327.64
When was Amgen last traded?
The last trade of Amgen was at 01/02/26 04:00 PM ET
What is the market capitalization of Amgen?
The market capitalization of Amgen is 176.43B
How many shares of Amgen are outstanding?
Amgen has 176B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.